Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | GLRA1 | P23415 | 2/20 | 0.66 |
| ▸ | GLRA2 | P23416 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | GUSB | P08236 | 1/20 | 0.66 |
| ▸ | PTAFR | P25105 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13702705 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL30331275 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL500085 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL16653652 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL500086 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL13960092 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL14078020 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL13702832 | 1.00 | KDM4E (1.00) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL14078047 | 0.94 | KDM4E (0.88) | KDM4EMAPK1GLRA1GLRA2CYP2C9 | |
| SCHEMBL13960101 | 0.93 | KDM4E (0.86) | KDM4EMAPK1GLRA1GLRA2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084755-B2 | Method for extracting and separating ginkgolides | CHENGDU BAIYU TECHNOLOGY PHARMACY CO., LTD. (CN) | 2015-07-21 | — | — | US | disclosed |
| US-9084755-B2 | Method for extracting and separating ginkgolides | CHENGDU BAIYU TECHNOLOGY PHARMACY CO., LTD. (CN) | 2015-07-21 | — | — | US | disclosed |
| US-20150044311-A1 | METHOD FOR EXTRACTING AND SEPARATING GINKGOLIDES | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2015-02-12 | — | — | US | disclosed |
| US-20150044311-A1 | METHOD FOR EXTRACTING AND SEPARATING GINKGOLIDES | CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) | 2015-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150044311-A1 | METHOD FOR EXTRACTING AND SEPARATING GINKGOLIDES | COG8, CYP8B1, GTPBP10 | KDM4E 3380/4885MAPK1 3051/4885GLRA1 1288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.